Lymphoma, Non-Hodgkin

"Lymphoma, Non-Hodgkin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Descriptor ID	D008228
MeSH Number(s)	C04.557.386.480 C15.604.515.569.480 C20.683.515.761.480
Concept/Terms	Lymphoma, Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma, Atypical Diffuse Small Lymphoid Lymphoma, Non-Hodgkin's Lymphoma, Non Hodgkin's Lymphoma, Non-Hodgkin, Familial Lymphoma, Non-Hodgkins Lymphoma, Non Hodgkins Non-Hodgkins Lymphoma Small Cleaved-Cell Lymphoma, Diffuse Small Cleaved Cell Lymphoma, Diffuse Lymphoma, Nonhodgkins Nonhodgkins Lymphoma Lymphoma, Small Cleaved Cell, Diffuse Lymphoma, Small Cleaved-Cell, Diffuse Non-Hodgkin Lymphoma Non Hodgkin Lymphoma Non-Hodgkin's Lymphoma Non Hodgkin's Lymphoma Diffuse Small Cleaved-Cell Lymphoma Diffuse Small Cleaved Cell Lymphoma Lymphoma, Nonhodgkin's Lymphoma, Nonhodgkin Nonhodgkin's Lymphoma Lymphoma, High-Grade Lymphoma, High-Grade High-Grade Lymphoma High-Grade Lymphomas Lymphoma, High Grade Lymphomas, High-Grade Lymphoma, Intermediate-Grade Lymphoma, Intermediate-Grade Intermediate-Grade Lymphoma Intermediate-Grade Lymphomas Lymphoma, Intermediate Grade Lymphomas, Intermediate-Grade Reticulum-Cell Sarcoma Reticulum-Cell Sarcoma Reticulum-Cell Sarcomas Sarcomas, Reticulum-Cell Reticulum Cell Sarcoma Reticulosarcoma Reticulosarcomas Sarcoma, Reticulum-Cell Sarcoma, Reticulum Cell Lymphoma, Mixed-Cell Lymphoma, Mixed-Cell Lymphoma, Mixed Cell Lymphoma, Mixed Lymphocytic-Histiocytic Lymphocytic-Histiocytic Lymphoma, Mixed Lymphocytic-Histiocytic Lymphomas, Mixed Lymphoma, Mixed Lymphocytic Histiocytic Lymphomas, Mixed Lymphocytic-Histiocytic Mixed Lymphocytic-Histiocytic Lymphoma Mixed Lymphocytic-Histiocytic Lymphomas Mixed-Cell Lymphoma Lymphomas, Mixed-Cell Mixed Cell Lymphoma Mixed-Cell Lymphomas Lymphoma, Mixed Lymphomas, Mixed Mixed Lymphoma Mixed Lymphomas Lymphoma, Mixed-Cell, Diffuse Lymphoma, Mixed-Cell, Diffuse Diffuse Mixed-Cell Lymphoma Diffuse Mixed Cell Lymphoma Diffuse Mixed-Cell Lymphomas Lymphoma, Diffuse Mixed-Cell Lymphomas, Diffuse Mixed-Cell Mixed-Cell Lymphomas, Diffuse Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic Mixed-Cell Lymphoma, Diffuse Mixed Cell Lymphoma, Diffuse Lymphoma, Mixed Small and Large Cell, Diffuse Lymphoma, Small and Large Cleaved-Cell, Diffuse Mixed Small and Large Cell Lymphoma, Diffuse Diffuse Mixed Small and Large Cell Lymphoma Lymphoma, Mixed Cell, Diffuse Lymphoma, Small Noncleaved-Cell Lymphoma, Small Noncleaved-Cell Lymphoma, Small Noncleaved Cell Small Non-Cleaved-Cell Lymphoma Small Non Cleaved Cell Lymphoma Lymphoma, Small Non-Cleaved-Cell Lymphoma, Small Non Cleaved Cell Lymphomas, Small Non-Cleaved-Cell Non-Cleaved-Cell Lymphoma, Small Non-Cleaved-Cell Lymphomas, Small Small Non-Cleaved-Cell Lymphomas Diffuse Undifferentiated Lymphoma Diffuse Undifferentiated Lymphomas Lymphoma, Diffuse Undifferentiated Lymphomas, Diffuse Undifferentiated Undifferentiated Lymphoma, Diffuse Undifferentiated Lymphomas, Diffuse Lymphoma, Undifferentiated, Diffuse Small Noncleaved-Cell Lymphoma Lymphomas, Small Noncleaved-Cell Noncleaved-Cell Lymphoma, Small Noncleaved-Cell Lymphomas, Small Small Noncleaved Cell Lymphoma Small Noncleaved-Cell Lymphomas Lymphoma, Undifferentiated Lymphoma, Undifferentiated Undifferentiated Lymphoma Lymphomas, Undifferentiated Undifferentiated Lymphomas Lymphoma, Pleomorphic Lymphomas, Pleomorphic Pleomorphic Lymphoma Pleomorphic Lymphomas Lymphoma, Diffuse Lymphoma, Diffuse Diffuse Lymphoma Diffuse Lymphomas Lymphomas, Diffuse Lymphosarcoma Lymphosarcomas Sarcoma, Lymphatic Lymphatic Sarcoma Lymphatic Sarcomas Sarcomas, Lymphatic Lymphoma, Low-Grade Lymphoma, Low-Grade Low-Grade Lymphoma Low-Grade Lymphomas Lymphoma, Low Grade Lymphomas, Low-Grade

Below are MeSH descriptors whose meaning is more general than "Lymphoma, Non-Hodgkin".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]

Below are MeSH descriptors whose meaning is related to "Lymphoma, Non-Hodgkin".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Non-Hodgkin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, Non-Hodgkin" by people in this website by year, and whether "Lymphoma, Non-Hodgkin" was a major or minor topic of these publications.

Bar chart showing 26 publications over 19 distinct years, with a maximum of 2 publications in 1997 and 2003 and 2007 and 2012 and 2014 and 2016 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1996	1	0	1
1997	1	1	2
1998	1	0	1
1999	1	0	1
2003	2	0	2
2004	1	0	1
2005	1	0	1
2006	1	0	1
2007	2	0	2
2008	1	0	1
2011	1	0	1
2012	1	1	2
2013	0	1	1
2014	2	0	2
2016	0	2	2
2017	1	1	2
2018	0	1	1
2019	1	0	1

Below are the most recent publications written about "Lymphoma, Non-Hodgkin" by people in Profiles.

Fox J, Ajinkya S, Houston P, Lindhorst S, Cachia D, Olar A, Kutluay E. Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features. J Neurol Sci. 2019 May 15; 400:34-38.

View in: PubMed
Baecklund E, Backlin C, Rönnelid J, Toes R, Huizinga T, Åhlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis. Scand J Rheumatol. 2018 07; 47(4):270-275.

View in: PubMed
Rozenvald IB, Richardson MD, Brock L, Maiese RL. Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity. Arch Pathol Lab Med. 2017 Jun; 141(6):837-840.

View in: PubMed
Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S, Bosworth A, Francisco L, He J, Bansal A, Morgan EA, Lacasce AS, Freedman AS, Fisher DC, Jacobsen E, Armand P, Alyea EP, Koreth J, Ho V, Soiffer RJ, Antin JH, Ritz J, Nikiforow S, Forman SJ, Michor F, Neuberg D, Bhatia R, Bhatia S, Ebert BL. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol. 2017 May 10; 35(14):1598-1605.

View in: PubMed
Bolduc P, Roder N, Colgate E, Cheeseman SH. Care of Patients With HIV Infection: Medical Complications and Comorbidities. FP Essent. 2016 Apr; 443:16-22.

View in: PubMed
Nason KS, Kirchner A, Schuchert MJ, Luketich JD, Christie NA, Pantanowitz L, Karunamurthy A, Monaco SE. Endobronchial Ultrasound-Transbronchial Needle Aspiration for Lymphoma in Patients With Low Suspicion for Lung Cancer and Mediastinal Lymphadenopathy. Ann Thorac Surg. 2016 May; 101(5):1856-63.

View in: PubMed
Bahceci A, Paydas S, Tanriverdi K, Ergin M, Seydaoglu G, Ucar G. DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma. Tumour Biol. 2015 Mar; 36(3):2155-61.

View in: PubMed
McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Aljurf MD, Akpek G, Bacher U, Chao NJ, Chen YB, Cooper BW, Dehn J, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ. Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biol Blood Marrow Transplant. 2014 Jul; 20(7):960-8.

View in: PubMed
Ponzoni M, Govi S, Licata G, Mappa S, Giordano Resti A, Politi LS, Spagnuolo L, Di Cairano E, Doglioni C, Ferreri AJ. A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma. Oncologist. 2013; 18(7):876-84.

View in: PubMed
Roy R, Evens AM, Patton D, Gallot L, Larson A, Rademaker A, Cilley J, Spies S, Variakojis D, Gordon LI, Winter JN. Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation. Leuk Lymphoma. 2013 Mar; 54(3):497-502.

View in: PubMed

People

Explore

Similar Concepts

Top Journals